FULVESTRANT

Description

Fulvestrant – Estrogen Receptor Antagonist for Breast Cancer Treatment

Fulvestrant is a prescription hormonal therapy drug classified as a selective estrogen receptor degrader (SERD). It is widely used for the treatment of hormone receptor-positive (HR+), HER2-negative advanced or metastatic breast cancer in postmenopausal women. Fulvestrant works by binding to estrogen receptors, blocking their activity, and accelerating receptor degradation, thereby slowing the growth of estrogen-dependent breast cancer cells.

At Oncomed Pharmacy, we provide authentic Fulvestrant injections from trusted manufacturers, ensuring patients receive safe, effective, and high-quality oncology medicines.

Key Features of Fulvestrant

• Indications:

o HR+ advanced or metastatic breast cancer in postmenopausal women

o First-line therapy or after disease progression on anti-estrogen therapy (e.g., tamoxifen)

o Used in combination with targeted therapies such as CDK4/6 inhibitors

• Formulation: Intramuscular (IM) injection, typically administered once monthly.
• Mechanism of Action: Selective estrogen receptor degrader (SERD) that binds, blocks, and degrades estrogen receptors.
• Patient Benefit: Effective in slowing disease progression with proven survival benefits in HR+ breast cancer patients.

Why Buy Fulvestrant from Oncomed Pharmacy?

• 100% genuine and quality-tested oncology medicines.
• Affordable pricing with reliable countrywide shipping.
• Cold-chain maintained packaging to preserve drug potency.
• Trusted oncology pharmacy specializing in hormonal therapy for breast cancer.

Uses of Fulvestrant

• Standard treatment for advanced HR+ breast cancer in postmenopausal women.
• Alternative option after failure of other endocrine therapies such as tamoxifen or aromatase inhibitors.
• Often combined with palbociclib, ribociclib, or abemaciclib for enhanced effectiveness.